Literature DB >> 2003418

The Geschwind syndrome.

D F Benson1.   

Abstract

A characteristic personality syndrome consisting of circumstantiality (excessive verbal output, stickiness, hypergraphia), altered sexuality (usually hyposexuality), and intensified mental life (deepened cognitive and emotional responses) is present in some epilepsy patients. For identification, the term "Geschwind syndrome" has been suggested as a name for this group of behavioral phenomena. Support for, and criticism against, the existence of this syndrome as a specific personality disorder has produced more fire than substance, but the presence of an unsettled, ongoing controversy has been acknowledged. At present, the strongest support stems from the many clinicians who have described and attempted to manage seizure patients with these personality features. Carefully directed studies are needed to confirm or deny that the Geschwind syndrome represents a specific epilepsy/psychiatric disorder.

Entities:  

Mesh:

Year:  1991        PMID: 2003418

Source DB:  PubMed          Journal:  Adv Neurol        ISSN: 0091-3952


  3 in total

Review 1.  Third International Congress on Epilepsy, Brain and Mind: Part 1.

Authors:  Amos D Korczyn; Steven C Schachter; Jana Amlerova; Meir Bialer; Walter van Emde Boas; Milan Brázdil; Eylert Brodtkorb; Jerome Engel; Jean Gotman; Vladmir Komárek; Ilo E Leppik; Petr Marusic; Stefano Meletti; Birgitta Metternich; Chris J A Moulin; Nils Muhlert; Marco Mula; Karl O Nakken; Fabienne Picard; Andreas Schulze-Bonhage; William Theodore; Peter Wolf; Adam Zeman; Ivan Rektor
Journal:  Epilepsy Behav       Date:  2015-08-11       Impact factor: 2.937

Review 2.  A Systematic Review of Psychiatric and Psychosocial Comorbidities of Genetic Generalised Epilepsies (GGE).

Authors:  A Loughman; N A Bendrups; W J D'Souza
Journal:  Neuropsychol Rev       Date:  2016-10-10       Impact factor: 7.444

3.  Hypergraphia in temporal lobe epilepsy.

Authors:  Giridhar P Kalamangalam
Journal:  Ann Indian Acad Neurol       Date:  2009-07       Impact factor: 1.383

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.